مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

17
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

6
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A Comparison between the Efficiency of Vonavir (Tenofovir-Emtricitabine-Efavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran

Pages

  319-324

Abstract

 Background & Objective: Many different combination regimens have been used for the treatment of patients infected with human immunodeficiency viruses (HIV). This study aimed to compare the efficacy of two antiviral drugs for the treatment of HIV-infected patients. Materials & Methods: This cross-sectional study was performed on HIV-positive patients in Fasa, Southwest Iran. Eighty patients were enrolled in the investigation who were then randomly divided into two groups and treated plus vonavir (Tenofovir-Emtricitabine-Efavirenz) and cobavir (Lamivudine-Zidovudine) with efavirenz for six months. Blood samples collected from all patients were examined for Viral load every six months using Real-time PCR and CD4 changes by flow cytometry. Result: During the six months of treatment, the CD4 response was not significantly increased in group one, treated with vonavir. In contrast, the CD4 value showed a significant increasing trend during the treatment course in group two treated with cobavir-efavirenz (P=0. 003). However, overall, there was no statistically significant difference between the CD4 responses of the two groups (P=0. 361). In addition, the plasma Viral load was significantly suppressed in both regimens (P< 0. 05). Conclusion: Hence, the two regimens (cobavir-efavirenz, and vobavir) showed the same efficacy on HIV patients according to the same suppression of Viral load, and CD4 response in this region. However, inclusion of more samples is needed and more studies are suggested in order to confirm our results as well.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    Honarmand, Saeideh, Montaseri, Zahra, Sharafi, Mehdi, & Najafipoor, Sohrab. (2022). A Comparison between the Efficiency of Vonavir (Tenofovir-Emtricitabine-Efavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran. JOURNAL OF ADVANCED BIOMEDICAL SCIENCES, 12(3), 319-324. SID. https://sid.ir/paper/1089805/en

    Vancouver: Copy

    Honarmand Saeideh, Montaseri Zahra, Sharafi Mehdi, Najafipoor Sohrab. A Comparison between the Efficiency of Vonavir (Tenofovir-Emtricitabine-Efavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran. JOURNAL OF ADVANCED BIOMEDICAL SCIENCES[Internet]. 2022;12(3):319-324. Available from: https://sid.ir/paper/1089805/en

    IEEE: Copy

    Saeideh Honarmand, Zahra Montaseri, Mehdi Sharafi, and Sohrab Najafipoor, “A Comparison between the Efficiency of Vonavir (Tenofovir-Emtricitabine-Efavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran,” JOURNAL OF ADVANCED BIOMEDICAL SCIENCES, vol. 12, no. 3, pp. 319–324, 2022, [Online]. Available: https://sid.ir/paper/1089805/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button